Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tabata workout may fight inflammation differently in smokers

NCT ID NCT07412639

Knowledge-focused Sponsor: Ataturk University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how a short, intense workout called Tabata affects certain inflammation-related substances in the blood. Researchers compared 40 smokers and non-smokers to see if exercise changes these markers differently. The goal was to better understand how smoking and exercise interact in the body.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Tabata exercise (a short, high-intensity interval workout)
What this could lead to
If successful, this could help explain how exercise reduces inflammation differently in smokers and non-smokers, possibly guiding future health advice.
What could go wrong
This is a small, early-stage study with only 40 participants. It measures biomarkers, not health outcomes, so real-world benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Oct 2025

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 40 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 18 and 40 years * No regular participation in structured physical exercise for at least 6 months prior to enrollment * Absence of any acute or chronic inflammatory disease at baseline * No history of cardiovascular, metabolic, pulmonary, or neurological disorders * Ability to comply with the study protocol and complete the tabata exercise program * Provision of written informed consent Exclusion Criteria: * Initiation or cessation of smoking during the study period * Use of anti-inflammatory, antioxidant, corticosteroid, or vasoactive medications * Acute infection, surgical intervention, or major trauma within the preceding 3 months * Diagnosis of diabetes mellitus, hypertension, coronary artery disease, or chronic pulmonary disease * History of alcohol or substance abuse * Pregnancy or breastfeeding * Musculoskeletal or orthopedic conditions that could limit participation in tabata exercise * Inability to adhere to the exercise protocol or failure to complete follow-up assessments

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Smoking are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cigarette Smoking Smoking

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Smoking Smoking ( cigarette)

Contacts and locations

Locations

  • Atatürk University

    Erzurum, Yakutiye, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.